Before Epilepsy Unfolds: Opening up the potassium door in neonatal seizures

There is increasing interest in understanding how epilepsy initiates and how to thwart the establishment of the disease. Many questions remain open as to what targets may the best for preventing epilepsy and whether any common triggering pathway exists to treat this complex malady. In 'Bedside to Bench', Rod C. Scott and Gregory Holmes discuss alternative therapies to treat neonatal seizures to prevent chronic cognitive impairment and brain developmental problems, which can lead to epilepsy later in life. Increasing inhibitory signals in the developing brain may be useful in dampening brain hyperexcitability—and enhanced susceptibility for seizures—and blocking epilepsy development in children. In 'Bench to Bedside', Annamaria Vezzani argues how the mTOR pathway may be a potential target for blocking epileptogenesis. The role of mTOR in seizures in early life and progression of established disease raises the possibility that mTOR could be a common mediator involved in epilepsy at different stages of disease initiation and progression. Given the lack of current antiepileptic drugs to prevent seizures in children and to block epileptogenesis, developing new disease-modifying therapies remains a priority.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Receptor and channel development in the newborn rat.


  1. 1

    Lanska, M.J. & Lanska, D.J. Neuroepidemiology 15, 117–125 (1996).

    CAS  Article  Google Scholar 

  2. 2

    Ronen, G.M., Buckley, D., Penney, S. & Streiner, D.L. Neurology 69, 1816–1822 (2007).

    Article  Google Scholar 

  3. 3

    Glass, H.C. et al. J. Pediatr. 155, 318–323 (2009).

    Article  Google Scholar 

  4. 4

    Painter, M.J. et al. N. Engl. J. Med. 341, 485–489 (1999).

    CAS  Article  Google Scholar 

  5. 5

    Bittigau, P. et al. Proc. Natl. Acad. Sci. USA 99, 15089–15094 (2002).

    CAS  Article  Google Scholar 

  6. 6

    Singh, N.A. et al. Brain 126, 2726–2737 (2003).

    Article  Google Scholar 

  7. 7

    Singh, N.A. et al. Nat. Genet. 18, 25–29 (1998).

    CAS  Article  Google Scholar 

  8. 8

    Singh, N.A. et al. J. Physiol. (Lond.) 586, 3405–3423 (2008).

    CAS  Article  Google Scholar 

  9. 9

    Weckhuysen, S. et al. Ann. Neurol. 71, 15–25 (2012).

    CAS  Article  Google Scholar 

  10. 10

    Ben-Ari, Y., Gaiarsa, J.L., Tyzio, R. & Khazipov, R. Physiol. Rev. 87, 1215–1284 (2007).

    CAS  Article  Google Scholar 

  11. 11

    Dzhala, V.I. et al. Nat. Med. 11, 1205–1213 (2005).

    CAS  Article  Google Scholar 

  12. 12

    Ben-Ari, Y. & Holmes, G.L. Lancet Neurol. 5, 1055–1063 (2006).

    Article  Google Scholar 

  13. 13

    Miceli, F., Soldovieri, M.V., Martire, M. & Taglialatela, M. Curr. Opin. Pharmacol. 8, 65–74 (2008).

    CAS  Article  Google Scholar 

  14. 14

    Schenzer, A. et al. J. Neurosci. 25, 5051–5060 (2005).

    CAS  Article  Google Scholar 

  15. 15

    Large, C.H. et al. Epilepsia 53, 425–436 (2012).

    CAS  Article  Google Scholar 

  16. 16

    Gunthorpe, M.J., Large, C.H. & Sankar, R. Epilepsia 53, 412–424 (2012).

    CAS  Article  Google Scholar 

  17. 17

    Sankar, R. et al. Epilepsia 51 (suppl. 3), 39–42 (2010).

    CAS  Article  Google Scholar 

  18. 18

    Mazarati, A., Wu, J., Shin, D., Kwon, Y.S. & Sankar, R. Epilepsia 49, 1777–1786 (2008).

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Gregory L Holmes.

Ethics declarations

Competing interests

Declaration: G.H. has previously served on the scientific advisory board of GlaxoSmithKline.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Scott, R., Holmes, G. Before Epilepsy Unfolds: Opening up the potassium door in neonatal seizures. Nat Med 18, 1624–1625 (2012).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing